In a new statement, Health Canada confirmed that the product monograph — or label — on AstraZeneca vaccines has been updated to include information about blood clots.
Following reports of “very rare adverse events” in Europe, the federal health agency confirmed that they had worked very closely with regulators to consider the evidence and update the vaccine’s label.
Going forward, it will include details on “very rare reports of blood clots associated with low levels of blood platelets (i.e., thrombocytopenia) following immunization with the AstraZeneca vaccine.”
That said, the agency reassures Canadians that it is both safe and effective at protecting against COVID-19, with Justin Trudeau adding, “To say it simply, the best vaccine for you is the first one offered to you."
To date, Health Canada says it has “not received any reports of these very rare events.”
Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.